AI-generated summary
The authors describe a protocol for a double-blind, randomized, placebo-controlled trial of multimodal photobiomodulation for chronic painful temporomandibular disorder. The trial plans to randomize 130 adults to active or sham treatment across eight visits, with pain intensity as the primary outcome. No results are reported, as this is a study protocol.
- Participants
- 130
- Who or what was studied
- Adults aged 18 years and older with chronic painful temporomandibular disorder
- Limits stated in the abstract
- This is a protocol with no outcome data, and the trial is single-site.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Randomized controlled trial, Photobiomodulation therapy, Placebo-controlled, Primary outcome, Inflammation, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.